Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease (Q34395823)

1 August 2017

1 reference

title

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease (English)

1 reference

1 August 2017

O Stanger

1

1 reference

1 August 2017

M Weger

series ordinal

2

1 reference

1 August 2017

W Renner

series ordinal

3

1 reference

1 August 2017

R Konetschny

series ordinal

4

1 reference

1 August 2017

1 August 2001

1 reference

Clinical Chemistry and Laboratory Medicine

1 August 2017

1 reference

1 August 2017

39

1 reference

1 August 2017

8

1 reference

1 August 2017

725-733

1 reference

Homocysteine and cardiovascular disease

1 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

HOMOCYSTINURIA: AN ENZYMATIC DEFECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

A derangement in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Generation of fibrinolytic activity by infusion of activated protein C into dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Clinical implications of prostaglandin and thromboxane A2 formation (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Hyperhomocyst(e)inemia and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Forearm composition contributes to differences in reactive hyperaemia between healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.121

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.121

1 reference

1 August 2017

1 reference